Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| FEDERAL MOGU | FDML | 5.91% |
| RADIANT LOGI | RLGT | 4.26% |
| NATUS MEDICA | BABY | 3.23% |
| ORBOTECH LTD | ORBK | 3.18% |
| INTEROIL COR | IOC | 3.02% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Lululemon Athletica Inc. ( LULU - Snapshot Report ) , the leading athletic apparel and accessories retailer in Canada, the U.S. and Australia, is scheduled to report its fourth-quarter 2011 financial results before the opening bell on March 22.
The current Zacks Consensus Estimate for earnings for the quarter is 49 cents a share. For the fourth quarter, revenue is expected at $360 million, according to the Zacks Consensus Estimate.
Third Quarter Recap
Lululemon posted earnings of 27 cents per share for third-quarter 2011, handily beating the Zacks Consensus Estimate of 25 cents and were 50% higher than the prior-year quarter’s earnings of 18 cents.
The company's 16% increase in comparable-store sales and 71% rise in Direct-to-Consumer revenues resulted in nearly 31% year-over-year surge in the quarter's revenues which came in at $230.2 million. However, revenues fell short of the Zacks Consensus Estimate of $234 million.
Fourth-quarter 2011 outlook
The yoga-inspired athletic apparel company forecasts its earnings for the fourth quarter to be in the range of 47 cents to 49 cents per share, an increase from its previous guidance of 40 cents to 42 cents. Lululemon is expecting earnings growth of approximately 47% to 53% from the prior-year quarter’s earnings of 32 cents per share, up from its previous forecasted range of 25% to 31%.
As per management, the existing store upgrades and new store openings have the potential to generate net revenues of $358 to $363 million for the fourth quarter of fiscal 2011 compared with $327 to $332 million guided earlier. The company also anticipates comps to grow in the range of low-to-mid twenties for the upcoming fourth quarter, instead of the earlier forecasted growth range of low-to-mid teens.
Zacks Consensus
The analysts covered by Zacks expect Lululemon to post fourth-quarter 2011 earnings of 49 cents a share, higher than 32 cents registered in the prior-year quarter. Currently, the Zacks Consensus Estimate ranges between 48 cents and 50 cents a share.
For fiscal 2011, the Zacks Consensus Estimate stood at $1.24 per share, higher than the previous fiscal earnings of 79 cents. The current Zacks Consensus Estimate for the fiscal ranges between $1.17 and $1.26 per share.
Agreement of Estimate
Of the 20 analysts covering the stock, none has revisited their estimates for the fourth quarter over the last 30 days. For the full year, 2 analysts revised their estimate in the positive direction over the last 30 days accompanied by a sole reverse movement.
Over the last 7 days, no movement in estimates has been noticed for the fourth quarter while for fiscal 2011, one analyst revised its estimate in the upward direction.
Magnitude of Estimate Revisions
With hardly any earnings revision by the analysts over the last 30 days, the Zacks Consensus Estimates for the fourth quarter of 2011 and fiscal 2011 remained unchanged at 49 cents and $1.24 per share, respectively.
Surprise History
With respect to earnings surprises, Lululemon has topped the Zacks Consensus Estimate over the last four quarters in the range of 8% to 18.2%. The average remained at positive 14.1%, suggesting that Lululemon has surpassed the Zacks Consensus Estimate by that measure in the trailing four quarters.
Our Take
We believe that Lululemon's continued focus on introducing technical athletic products made from innovative and diversified fabrics such as yoga pants and tops will further enhance its market proposition. Further, the company’s continuous strategic investments to expand its global footprint while evaluating the performance of existing stores will further boost both its top and bottom lines.
The company currently competes with retailers such as Nike Inc. ( NKE - Analyst Report ) and Under Armour Inc. ( UA - Snapshot Report ) , which intend to grab market share in active wear or lifestyle consumer products. Moreover, the athletic apparel industry is characterized by rapidly changing customer preferences and technology. We believe that Lululemon’s continuous focus on product innovation will keep it ahead of its competitors.
We are retaining our long-term ‘Outperform’ recommendation on the stock. Currently, Lululemon maintains a Zacks #1 Rank, which translates into a short-term ‘Strong Buy’ rating.
Read the full Snapshot Report on UA
Read the full Analyst Report on NKE
Read the full Snapshot Report on LULU